Surgical Myocardial Revascularization versus Percutaneous Coronary Intervention with Drug-Eluting Stents in Octogenarian Patients

被引:5
|
作者
Ben-Gal, Yanai [1 ]
Finkelstein, Ariel [1 ]
Banai, Shmuel [1 ]
Medalion, Benjamin [2 ]
Weisz, Giora [3 ]
Genereux, Philippe [3 ]
Moshe, Shelly [1 ]
Pevni, Dmitry [1 ]
Aviram, Galit [1 ]
Uretzky, Gideon [1 ]
机构
[1] Tel Aviv Sourasky Med Ctr, IL-64239 Tel Aviv, Israel
[2] Rabin Med Ctr, Petah Tiqwa, Israel
[3] Columbia Univ Med Ctr, New York Presbyterian Hosp, New York, NY USA
来源
HEART SURGERY FORUM | 2012年 / 15卷 / 04期
关键词
LONG-TERM SURVIVAL; ARTERY-BYPASS; FOLLOW-UP; OUTCOMES; SURGERY; IMPLANTATION; ANGIOPLASTY; EXPERIENCE; MORTALITY; GRAFT;
D O I
10.1532/HSF98.20111190
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Our goal was to compare the clinical outcomes of octogenarian (or older) patients who are referred for either surgical or percutaneous coronary revascularization. Methods: We retrospectively evaluated the outcomes of all patients 80 years of age who had undergone coronary artery bypass grafting (CABG) with an internal mammary artery or had undergone a percutaneous coronary intervention (PCI) with a sirolimus-eluting stent to the left anterior descending artery in our center between May 2002 and December 2006. Results: Of the 301 patients, 120 underwent a PCI, and 181 underwent CABG. Surgical patients had higher rates of left main disease, triple-vessel disease, peripheral vascular disease, emergent procedures, and previous myocardial infarctions (39.7% versus 3.3% [P = .001], 76.1% versus 28.3% [P = .0001], 19.6% versus 7.5% [P = .004], 15.8% versus 2.5% [P = .0001], and 35.9% versus 25% [P = .04], respectively). CABG patients had a higher early mortality rate (9.9% versus 2.5%, P = .01). There were no differences in 1- and 4-year actuarial survival rates, with rates of 90% and 68%, respectively, for the PCI group and 85% and 71% for the CABG group (P = .85). The rates of actuarial freedom from major adverse cardiac events (MACEs) at 1 and 4 years were 83% and 75%, respectively, for the PCI group, and 86% and 78% for the CABG group (P = .33). The respective rates of freedom from reintervention were 87% and 83% for the PCI group, versus 99% and 97% for the CABG group (P < .001). The 4-year rate of freedom from recurring angina was 58% for the PCI group, versus 88% for CABG patients (P < .001). Revascularization strategy was not a predictor of adverse outcome in a multivariable analysis. Conclusion: Octogenarian CABG patients were sicker and experienced a higher rate of early mortality. The 2 strategies had similar rates of late mortality and MACEs, with fewer reinterventions and recurring angina occurring following surgery.
引用
收藏
页码:E204 / E209
页数:6
相关论文
共 50 条
  • [31] Percutaneous coronary intervention in patients with cancer using bare metal stents compared to drug-eluting stents
    Ahmed, Talha
    Pacha, Homam Moussa
    Addoumieh, Antoine
    Koutroumpakis, Efstratios
    Song, Juhee
    Charitakis, Konstantinos
    Boudoulas, Konstantinos Dean
    Cilingiroglu, Mehmet
    Marmagkiolis, Konstantinos
    Grines, Cindy
    Iliescu, Cezar A.
    [J]. FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [32] What is the preferred strategy for revascularization of patients with multivessel disease: Percutaneous coronary intervention with drug-eluting stents or coronary artery bypass surgery?
    Javaid, Aamir
    Buch, Ashesh N.
    Xue, Zhenyi
    Corso, Paul F.
    Satler, Lowell F.
    Kent, Kenneth M.
    Pichard, Augusto D.
    Pichard, Augusto D.
    Waksman, Ron
    [J]. CIRCULATION, 2006, 114 (18) : 434 - 434
  • [33] TRANSRADIAL VERSUS TRANSFEMORAL INTERVENTION IN ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION PATIENTS UNDERGOING PRIMARY PERCUTANEOUS CORONARY INTERVENTION WITH DRUG-ELUTING STENTS
    Rha, Seung-Woon
    Li, Hu
    Choi, Byoung Geol
    Choi, Yeon
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (12) : A1837 - A1837
  • [34] Transradial versus Transfemoral Intervention in ST-Segment Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention with Drug-eluting Stents
    Rha, Seung-Woon
    Park, Ji Young
    Choi, Cheol Ung
    Oh, Dong Joo
    Cho, Byung Ryul
    Kim, Moo Hyun
    Kim, Doo-Il
    Jeong, Myung-Ho
    Yoo, Sang Yong
    Jeong, Sang-Sik
    Kim, Byung Ok
    Hyun, Min Su
    Yoon, Junghan
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2011, 107 (8A): : 38A - 39A
  • [35] Drug-eluting stents in patients with left main coronary lesions who are not candidates for surgical revascularization
    Lozano, F
    Herrera, C
    Morís, C
    Gómez-Hospital, JA
    Rondán, J
    Iráculis, E
    Martín, M
    Cequier, A
    Suárez, E
    Esplugas, E
    [J]. REVISTA ESPANOLA DE CARDIOLOGIA, 2005, 58 (02): : 145 - 152
  • [36] Hybrid coronary revascularization in the era of drug-eluting stents
    Murphy, GJ
    Bryan, AJ
    Angelini, GD
    [J]. ANNALS OF THORACIC SURGERY, 2004, 78 (05): : 1861 - 1867
  • [37] What reimbursement for coronary revascularization with drug-eluting stents?
    Tarricone R.
    Marchetti M.
    Lamotte M.
    Annemans L.
    De Jong P.
    [J]. The European Journal of Health Economics, 2004, 5 (4) : 309 - 316
  • [38] Drug-eluting stents Implications for modern coronary revascularization
    Martens, A.
    Haverich, A.
    [J]. CHIRURG, 2009, 80 (06): : 508 - +
  • [39] Early and Late Outcomes of Coronary Artery Bypass Surgery Versus Percutaneous Coronary Intervention with Drug-Eluting Stents for Dialysis Patients
    Terazawa, Sachie
    Tajima, Kazuyoshi
    Takami, Yoshiyuki
    Tanaka, Keisuke
    Okada, Noritaka
    Usui, Akihiko
    Ueda, Yuichi
    [J]. JOURNAL OF CARDIAC SURGERY, 2012, 27 (03) : 281 - 287
  • [40] Gender disparity in the use of drug-eluting stents during percutaneous coronary intervention for acute myocardial infarction
    Iyanoye, Adeyemi
    Moreyra, Abel E.
    Swerdel, Joel N.
    Gandhi, Sampada K.
    Cabrera, Javier
    Cosgrove, Nora M.
    Kostis, John B.
    [J]. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2015, 86 (02) : 221 - 228